ID
17648
Description
Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc ( OSI Pharmaceuticals ) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Part of Study: Post-Treatment Assessments
Link
https://clinicaltrials.gov/ct2/show/NCT00373425
Keywords
Versions (3)
- 7/27/16 7/27/16 -
- 8/1/16 8/1/16 -
- 9/27/16 9/27/16 -
Uploaded on
September 27, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Post-Treatment Assessments, Tarceva in NSCLC patients who have EGFR-positive tumors DRKS00001485 NCT00373425
Post-Treatment Assessments, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425
Description
Physical Examination
Alias
- UMLS CUI-1
- C0031809
Description
Pregnancy Test
Alias
- UMLS CUI-1
- C0032976
Description
If applicable: Was pregnancy test performed?
Data type
boolean
Alias
- UMLS CUI [1]
- C0032976
Description
Date of Collection
Data type
date
Alias
- UMLS CUI [1,1]
- C1516698
- UMLS CUI [1,2]
- C0032976
- UMLS CUI [1,3]
- C0011008
Description
Accession Number
Data type
text
Alias
- UMLS CUI [1]
- C2826726
Description
Pregnancy Test
Data type
boolean
Alias
- UMLS CUI [1]
- C0032976
Description
Biochemistry/Proteomics
Description
Reason Off Treatment
Description
Death
Alias
- UMLS CUI-1
- C0011065
Description
Did the patient die before the Post-treatment visit? (If Yes, complete section below as well as Adverse Events page and Serious Adverse Event Report Form)
Data type
boolean
Alias
- UMLS CUI [1]
- C0011065
Description
Primary Cause of Death
Data type
integer
Alias
- UMLS CUI [1]
- C0007465
Description
Cause of death
Data type
text
Alias
- UMLS CUI [1]
- C0007465
Description
Autopsy
Data type
integer
Alias
- UMLS CUI [1]
- C0004398
Description
Investigator Signature
Description
I have reviewed the data recorded in this Case Report Form. To the best of my knowledge, it is a complete and accurate representation of the patient's status during the study.
Data type
text
Alias
- NCI Thesaurus ValueDomain
- C25704
- NCI Thesaurus Property
- C25678
- NCI Thesaurus ObjectClass
- C17089
- UMLS CUI [1]
- C2346576
Description
Investigator Signature Date
Data type
date
Alias
- NCI Thesaurus ObjectClass
- C19464
- NCI Thesaurus Property
- C25250
- NCI Thesaurus Property-2
- C25604
- NCI Thesaurus ValueDomain
- C25164
- NCI Thesaurus ValueDomain-2
- C25367
- UMLS CUI [1,1]
- C2346576
- UMLS CUI [1,2]
- C0011008
Similar models
Post-Treatment Assessments, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425
C0032976 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,2])
C25678 (NCI Thesaurus Property)
C17089 (NCI Thesaurus ObjectClass)
C2346576 (UMLS CUI [1])
C25250 (NCI Thesaurus Property)
C25604 (NCI Thesaurus Property-2)
C25164 (NCI Thesaurus ValueDomain)
C25367 (NCI Thesaurus ValueDomain-2)
C2346576 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])